Infrared RX, Inc.
Athens, GA
- UEI
- WCBQFL361VY1
- CAGE
- 75U48
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 210 Spring St #130, Athens, GA 30602, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| MOC analysis | Naval Sea Systems Command (Navy) | $5,000 |
Grant awards
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| University Of Massachusetts Medical School | U54HL143541 | $83,388 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Bridgesource Medical, Corp. | Austin, TX | 541330 Engineering Services |
| Mercator Medsystems, Inc. | San Leandro, CA | 339112 Surgical and Medical Instrument Manufacturing |
| Perimed Inc. | Las Vegas, NV | 339112 Surgical and Medical Instrument Manufacturing |
| Semler Scientific Inc. | Campbell, CA | 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing |
| CSI | — | 339112 Surgical and Medical Instrument Manufacturing |
About the company
Infrared RX, Inc. is a for-profit corporation that provides goods and services to the federal government through contract and grant awards. The company develops medical technology, including non-invasive diagnostic tools and therapeutics for conditions like peripheral artery disease.
Through federal contract awards, Infrared RX, Inc. has provided services like analysis support to agencies such as the Department of the Navy Naval Sea Systems Command. In one contract award for "MOC ANALYSIS" valued at $5,000, the company delivered analytical services to the agency through a purchase order contract vehicle with no set-aside designation.
Infrared RX, Inc. has also received significant grant funding from agencies like the Department of Health and Human Services National Institutes of Health National Institute on Aging. A notable $755,783 Project Grant award supported the development of oxygen-guided therapy technology for optimizing rehabilitation for peripheral artery disease. The grant funding aimed to enhance resources, promote workforce diversity, and advance technology development to serve patients with disabling peripheral artery disease. Additionally, Infrared RX, Inc. has participated as a sub-awardee on grants led by prime recipients like the University of Massachusetts Medical School. These sub-awards funded pilot clinical trials to validate the accuracy, reliability, and usability of Infrared RX's non-invasive diagnostic technology for peripheral artery disease in diabetic patients, compared to standard techniques like ankle-brachial index testing and angiography.
Quick answers
Is Infrared RX, Inc. registered in SAM.gov?
Yes. Infrared RX, Inc.'s SAM.gov registration is active through September 9, 2027.
What is Infrared RX, Inc.'s most recent federal award?
Infrared RX, Inc.'s most recent federal grant award is Oxygen-guided therapy for optimal rehabilitation for peripheral artery disease (R41AG074788), from National Institute on Aging (NIH), on September 30, 2021.
On GovTribe
See Infrared RX, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors